COST OF THERAPY INCURRED FOR TUBERCULOSIS PATIENTS RECEIVING DIRECTLY OBSERVED THERAPY (DOT)

Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 11

Abstract

Objective: To estimate the cost of therapy of tuberculosis patients registered under DOTS program in the treatment of tuberculosis.Methods: A prospective observational study was conducted over a period of nine months in the Pulmonary Department of Bharati hospital and Research centre, Pune. 97 patients registered under RNTCP between August 2014 and April 2015, were interviewed at two time points: one at the time of first hospital visit and second on the completion of treatment. During the interview, information relating to various costs such as direct (out of pocket) and indirect cost was collected.Results: The mean total cost for Pulmonary tuberculosis treatment was found to be/5474.7 ($85.4), Extra pulmonary was/10574.8 ($164.9) and Pulmonary and Extra pulmonary was/14638.5 ($228.3) respectively. Out of total cost the cost incurred by the patients for the hospital stay and diagnosis (i.e. tuberculosis detection) has the maximum expenditure cost which was 90.4 % for pulmonary tuberculosis, 77.2% extra pulmonary and 72.5% pulmonary and extra pulmonary. About 39.2 % of patients and their care takers lost work days. 52.0% pulmonary patients, 68.4% extra-pulmonary and 66.7 % pulmonary and extra-pulmonary patients had decreased earning ability due to illness. Conclusion: The maximum cost is incurred for diagnosis and hospital stay in tuberculosis patients. Though DOTS strategy can help to reduce cost, achieve effective cure and save life of TB patients, still patients need to spend for other investigations and other drugs. 

Authors and Affiliations

Manjusha Sajith, Ansu Thomas, Jaydeep J Kothia, Bhumika Chandrakar, Atmaram Pawar, Medha Deepak Bargaje

Keywords

Related Articles

ANTIMICROBIAL, ANTIOXIDANT, CYTOTOXIC ACTIVITIES AND PHYTOCHEMICAL ASSESSMENT OF COLA ACUMINATA USED IN BENIN

Objective: The aim of this study was to make a phytochemical screening and measure some biological activities of Cola acuminata’s seeds and leaves extracts.Methods: The secondary metabolite was detected by the method b...

ASSESSMENT OF CYP2D6*10 POLYMORPHISM WITH POST HERPETIC NEURALGIA PATIENTS UNDERGOING TRAMADOL TREATMENT

objective: To evaluate association of CYP2D6*10 polymorphism with respect to demographic characteristics (age at onset, genders and weight), numerical rating scale (NRS) for measuring pain intensity in relation with rest...

EQUILIBRIUM, ISOTHERM, KINETIC AND THERMODYNAMIC ADSORPTION STUDIES OF TETRACYCLINE HYDROCHLORIDE ONTO COMMERCIAL GRADE GRANULAR ACTIVATED CARBON

Objective: The work presented here reveals the adsorption pattern of Tetracycline Hydrochloride (TC-HCl) onto granular activated carbon (GAC) in a batch process.Methods: Initially the consequence of various factors such...

COMPARATIVE EVALUATION OF XANTHAN, GUAR AND TREATED GUAR GUMS AS DRUG RELEASE BARRIERS IN ORAL MATRICES

Objective: This study addresses comparative efficiency of three natural gums, namely, xanthan gum, guar gum and thermally treated guar gum, as drug release barriers for sparingly and free water soluble model drugs.Method...

IDENTIFICATION OF POTENT BROMODOMAIN4 (BRD4) INHIBITORS BY ENERGY-PHARMACOPHORE BASED VIRTUAL SCREENING TO TARGET BRD4-NUT MIDLINE CARCINOMA

Objective: Protein-protein interactions (PPI’s) have been used as a target in various diseases. One such major role of PPI’s comes when the protein Bromodomain4 (BRD4) reads the epigenetic changes in the histones and...

Download PDF file
  • EP ID EP578237
  • DOI -
  • Views 44
  • Downloads 0

How To Cite

Manjusha Sajith, Ansu Thomas, Jaydeep J Kothia, Bhumika Chandrakar, Atmaram Pawar, Medha Deepak Bargaje (2015). COST OF THERAPY INCURRED FOR TUBERCULOSIS PATIENTS RECEIVING DIRECTLY OBSERVED THERAPY (DOT). International Journal of Pharmacy and Pharmaceutical Sciences, 7(11), 141-144. https://europub.co.uk/articles/-A-578237